Rankings
▼
Calendar
PLRX Q1 2025 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PLRX
Pliant Therapeutics, Inc.
$85M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$59M
Net Income
-$56M
EPS (Diluted)
$-0.92
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$49M
Free Cash Flow
-$49M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$345M
Total Liabilities
$88M
Stockholders' Equity
$257M
Cash & Equivalents
$92M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$513,000
+100.0%
Operating Income
-$59M
-$52M
-12.5%
Net Income
-$56M
-$47M
-19.6%
← Q4 2024
All Quarters
Q2 2025 →